In the present study, we investigated the expression of survivin and p53 using immunohistochemistry (IHC) in human rectal cancer tissues obtained from surgical specimens, and analyzed associations between expression and clinical outcomes in terms of disease recurrence and survival duration. Here, BIRC5 is linked to rectal cancer.